US11260088B2ActiveUtilityA1
Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
Est. expiryJun 21, 2037(~11 yrs left)· nominal 20-yr term from priority
A61K 47/46A61K 31/145A61K 47/14A61K 31/708A61K 31/4188A23L 33/21A61K 31/7072A61K 47/44A23V 2002/00A61K 33/26A23L 33/10A61K 31/4415A61K 31/593A61K 9/107A61K 47/12A61K 47/24A23L 33/155A61K 31/047A61K 47/26A61K 47/22A23L 33/15A23L 33/40A61K 47/36A61K 33/06A61K 35/745A61K 31/355A23L 33/125A61K 33/30A61K 31/205A61K 31/7076A61K 31/122A61K 47/02A61K 31/519A61K 31/015A23L 33/135A61K 47/42A61K 31/525A61K 31/702A61K 31/405A61K 31/714A61K 31/14A61K 35/747A61P 1/14A61K 31/07A61K 35/20
80
PatentIndex Score
3
Cited by
34
References
17
Claims
Abstract
Disclosed are nutritional compositions including 2′-fucosyllactose (2′-FL) in combination with lutein and RRR-alpha-tocopherol. The nutritional compositions are useful for improving at least one of gut function, health, and development in an individual. In certain embodiments, the nutritional compositions can improve growth or maturation of the gut, as well as promote a healthy balance of beneficial bacteria in the gastrointestinal tract thereby treating and/or preventing formula intolerance or other gastrointestinal diseases and/or disorders resulting from suboptimal gastrointestinal flora population/balance.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method of improving the gut health of an infant, the method comprising administering an amount of a nutritional composition comprising therapeutically effective amounts of the human milk oligosaccharide 2 ′-fucosyllactose, lutein, and RRR-alpha-tocopherol to the infant.
2. The method of claim 1 , wherein administration increases beneficial bacteria in the gut of the infant.
3. The method of claim 1 , wherein the nutritional composition comprises 2′-fucosyllactose in an amount of about 0.02 mg/mL to about 20 mg/mL.
4. The method of claim 1 , wherein the nutritional composition comprises lutein in an amount of about 0.001 mg/mL to about 5 mg/mL.
5. The method of claim 1 , wherein the nutritional composition comprises RRR-alpha-tocopherol in an amount of about 3 mg/L to about 100 mg/L.
6. The method of claim 1 , wherein the nutritional composition is an infant formula.
7. The method of claim 1 , wherein the nutritional composition further comprises a probiotic.
8. The method of claim 1 , wherein the probiotic is a Bifidobacterium.
9. The method of claim 1 , wherein the nutritional composition further comprises a second human milk oligosaccharide.
10. A method of increasing the beneficial bacteria in the gastrointestinal tract of an infant in need thereof, the method comprising administering an amount of a nutritional composition comprising therapeutically effective amounts of the human milk oligosaccharide 2 ′-fucosyllactose, lutein, and RRR-alpha-tocopherol to the infant.
11. The method of claim 10 , wherein the beneficial bacteria is at least one of a Bifidobacterium and a Lactobacillus.
12. The method of claim 10 , wherein the nutritional composition comprises 2′-fucosyllactose in an amount of about 0.02 mg/mL to about 20 mg/mL.
13. The method of claim 10 , wherein the nutritional composition comprises lutein in an amount of about 0.001 mg/mL to about 5 mg/mL.
14. The method of any claim 10 , wherein the nutritional composition comprises RRR-alpha-tocopherol in an amount of about 3 mg/L to about 100 mg/L.
15. The method claim 10 , wherein the nutritional composition is an infant formula.
16. The method claim 10 , wherein the nutritional composition further comprises a probiotic.
17. The method of claim 10 , wherein the nutritional composition further comprises a second human milk oligosaccharide.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.